Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
Revance Therapeutics, Inc. (RVNC) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/14/2023 8-K Other Events  Interactive Data
08/08/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/08/2023 8-K Quarterly results
Docs: "Revance Reports Second Quarter 2023 Financial Results, Provides Corporate Update"
08/03/2023 144 Form 144 - Report of proposed sale of securities:
07/03/2023 144 Form 144 - Report of proposed sale of securities:
07/03/2023 144 Form 144 - Report of proposed sale of securities:
06/15/2023 144 Form 144 - Report of proposed sale of securities:
06/09/2023 144 Form 144 - Report of proposed sale of securities:
06/09/2023 144 Form 144 - Report of proposed sale of securities:
06/02/2023 144 Form 144 - Report of proposed sale of securities:
06/01/2023 144 Form 144 - Report of proposed sale of securities:
05/15/2023 144 Form 144 - Report of proposed sale of securities:
05/12/2023 144 Form 144 - Report of proposed sale of securities:
05/12/2023 144 Form 144 - Report of proposed sale of securities:
05/12/2023 144 Form 144 - Report of proposed sale of securities:
05/12/2023 144 Form 144 - Report of proposed sale of securities:
05/09/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/09/2023 8-K Quarterly results
Docs: "Revance Reports First Quarter 2023 Financial Results, Provides Corporate Update"
05/08/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
05/01/2023 144 Form 144 - Report of proposed sale of securities:
04/19/2023 8-K Quarterly results
03/31/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
03/23/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
03/23/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/08/2023 144 Form 144 - Report of proposed sale of securities:
02/28/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
02/28/2023 8-K Quarterly results
02/14/2023 SC 13G Polar Capital Holdings Plc reports a 5.9% stake in Revance Therapeutics, Inc.
02/14/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/13/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/09/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/09/2023 SC 13G/A VANGUARD GROUP INC reports a 5.5% stake in Revance Therapeutics Inc.
02/03/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/03/2023 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy